Open AccessHow democratic institutions dealt with COVID-19: A case study of the United States of America and France
Author(s) -
Robert D. Willows
Publication year - 2022
Language(s) - English
DOI - 10.35293/ah.v7i.3940
Subject(s) - democracy , political science , public administration , presidential system , covid-19 , pandemic , politics , government (linguistics) , state (computer science) , law , medicine , linguistics , philosophy , disease , pathology , algorithm , computer science , infectious disease (medical specialty)
This paper analyses the democratic institutions of the United States and France,regarding the media, science, and politics relating to COVID-19 pandemic. Asdemocratic institutions are central to this paper, it is extensively defined, avoidingany possible vagueness that an incoherent definition might provide. Furthermore,the conditions that resulted from the COVID-19 virus are analysed, focusing onthe fiscal stimulus and public health protocols, and comparing them in relation toboth the United States and France. The focus shifts to the drugshydroxychloroquine and remdesivir, exploring the conditions around the drugs,analysing and comparing the actions institutions have taken within the respectivenations, as well as between the nations. The institutions that are key in bothnations include the presidential offices and the representatives of the presidents.The Food and Drug Administration (FDA) in the United States, the CS-COVIDcouncil that was created to handle the protocols and regulations in France, Thedecentralised Federal government of the United States, and the centralisedUnitary State of France are critical in the comparison of the institutions andactions relating to the pandemic.